Shares of plant-based meat company Beyond Meat (NASDAQ: BYND) fell over 6% on Friday on high volatility after short-selling firm Citron Research said in a tweet that the company was “beyond stupid.”
The research agency tweeted, “$BYND has become Beyond Stupid. Most heavily traded retail stock on Robinhood, market cap now bigger than industry, and superior competitor coming to market soon. We expect $BYND to go back to $65 on earnings On retail exhaustion.”
Beyond Meat, which started trading on May 2 at an offer price of $25, ended the first day of trading at $65.75. Till date, the stock is up 271.68%, reminiscing the days that led up to the dot-com crash.
The company’s market cap has increased from $3.83 billion on the first day of trading to the current $5.5 billion, which has led bears to suggest that a free fall may be in the making. We had reported earlier on the illogicality of the company’s valuation, as compared to its revenues.
READ: MOVE OVER LYFT AND UBER: 3 PROMISING STOCKS THAT STARTED TRADING TODAY
The El Segundo, California-based firm’s annual revenues increased 175% in 2018 to $88 million. However, the company’s valuation represents over 62 times its annual revenues, which is an outlandish figure given that the company hardly makes any money.
Despite the stock rally and the optimism in the market, there has been a drastic increase in people shorting the stock. As per the latest stats, over 40% of its shares are currently being shorted, indicating that more people are finding Beyond Meat’s valuation ludicrous and expect it to fall shortly.
Most Popular
QCOM Earnings: Qualcomm Q2 2024 revenue and profit beat Street view
Semiconductor company Qualcomm, Inc. (NASDAQ: QCOM) reported an increase in earnings and revenues for the second quarter of 2024. The numbers came in above analysts' estimates. At $9.39 billion, March-quarter
Key takeaways from Amazon’s Q1 2024 earnings report
Amazon.com Inc. (NASDAQ: AMZN) had an upbeat start to fiscal 2024, delivering strong growth across the business in the first three months of the year. While the cloud segment continues
Key takeaways from Pfizer’s (PFE) Q1 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) gained over 5% on Wednesday following the company’s announcement of its first quarter 2024 earnings results. Although the top and bottom line numbers decreased
Comments